ARTICLE | Company News
Deltanoid, Pfizer deal
January 20, 2003 8:00 AM UTC
Deltanoid granted PFE an option to acquire development and marketing rights to its 2MD, an analog of vitamin D, to treat osteoporosis. PFE also would receive rights to certain other Deltanoid vitamin...